Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2026 financial results after market close on ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its second-quarter financial results on Wednesday, ...

Bausch Health, Canada Inc., a subsidiary of Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC), announces the listing of ...

CEO Thomas Appio said, “We began 2026 with another strong performance,” and highlighted “12 consecutive quarters of year-over-year growth in both revenue and adjusted EBITDA for Bausch Health, ...

The facility will be collateralized by certain accounts receivables originated by a subsidiary of Bausch Health Bausch Health expects to utilize the proceeds of the facility for general corporate ...

Bausch Health Cos. (BHC) reported abysmal first-quarter results before the opening bell Tuesday. Revenue of $1.92 billion, flat year over year on an organic basis, missed expectations of $2.03 billion ...

Shares of Bausch Health Cos. Inc. tumbled 32.0% in premarket trading on Tuesday after the company missed revenue and earnings expectations for the first quarter. The company also offered revenue ...

There's a good reason why Bausch Health shares are experiencing yet another pullback. A recent clinical trial setback points to further trouble ahead. Buying on this latest round of weakness could ...

Bausch Health (NYSE: BHC) stock has been on a wild ride recently, with a dramatic surge in value over the last month. The catalyst for this surge is a wave of rumors suggesting that Bausch + Lomb ...

Bausch Health’s gastroenterology unit Salix Pharmaceuticals has chalked up a win in its long-running fight to fend off a generic to its irritable bowel syndrome diarrhea (IBD-D) med Xifaxan. This week ...

Valeant got into trouble nearly a decade ago after using debt to buy up several pharmaceutical companies, then subsequently slashing research budgets and raising prices. After the debt caught up with ...

Bausch Health Companies reports quarterly revenue of $2.56 billion which beat the analyst consensus estimate of $2.52 billion. Bausch Health sees fiscal 2025 revenue in a range of $9.9 billion to ...